# Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial

> **NCT00009230** · PHASE3 · COMPLETED · sponsor: **University of California, Los Angeles**

## Conditions studied

- Memory Disorders

## Interventions

- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00009230
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2005-06
- **Final completion:** 2005-08
- **Target enrollment:** — (—)
- **Last updated:** 2020-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00009230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00009230, "Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00009230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*